Travere Therapeutics, Inc. data breach

Clerk's notes

Travere Therapeutics, Inc., a biopharmaceutical company focused on rare diseases, officially reported a data breach to the New Hampshire Attorney General on October 27, 2025. This disclosure indicates that personal information maintained by the company may have been compromised. Individuals who have received an official data breach notification letter from Travere Therapeutics are directly affected by this incident.

The specific details concerning the nature of this breach and the precise categories of personal information involved have not been publicly disclosed. Currently, the incident is undergoing investigation. If you received a notification, it means your personal data was potentially part of this security event, though the full scope is still being determined.

For those who received a data breach notification, it is crucial to carefully review the letter for specific details provided by Travere Therapeutics. This document should outline the type of information involved, if known, and any protective measures or identity theft protection services offered by the company. It is always prudent to monitor your accounts and financial statements for any unusual activity.

Understanding the implications of a data breach can be complex. If you have received a notification regarding the Travere Therapeutics incident, you may wish to seek a free case review to explore your options. Our aim is to provide clarity on your situation without promising any specific legal outcome, as this is attorney advertising.

If a notification letter about this breach reached you, see every New Hampshire data breach on file or browse all cases.